Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Canada Clear all

148 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20042
20057
20062
20076
20084
20091
20102
20114
20121
20132
20142
20159
20166
20175
201812
20199
20209
202113
20226
202310
20247
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Recruiting30
Active, not recruiting25
Terminated22
Unknown status7
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
University Health Network, Toronto10
Merck Sharp & Dohme LLC8
Bristol-Myers Squibb7
National Cancer Institute (NCI)6
Pfizer5
Astellas Pharma Global Development, Inc.4
Eli Lilly and Company4
Hoffmann-La Roche4
Alliance for Clinical Trials in Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms148
Carcinoma, Transitional Cell34
Carcinoma, Non-Small-Cell Lung16
Ovarian Neoplasms16
Non-Muscle Invasive Bladder Neoplasms15
Breast Neoplasms11
Melanoma11
Prostatic Neoplasms11
Uterine Cervical Neoplasms11
Colorectal Neoplasms10

Trials

Showing 26 to 50 of 148. Each trial links to its page on Pharma Observatory.

48 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.